Published in Br J Haematol on February 24, 2017
The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med (2008) 6.41
The discovery of captopril. FASEB J (2003) 2.87
Snake bite in South Asia: a review. PLoS Negl Trop Dis (2010) 2.67
Snake envenoming: a disease of poverty. PLoS Negl Trop Dis (2009) 2.20
Molecular evolution and phylogeny of elapid snake venom three-finger toxins. J Mol Evol (2003) 2.14
Snake bite: a global failure to act costs thousands of lives each year. BMJ (2015) 1.93
Failure of a new antivenom to treat Echis ocellatus snake bite in rural Ghana: the importance of quality surveillance. Trans R Soc Trop Med Hyg (2008) 1.93
Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom. Biochemistry (1970) 1.86
Snake venom variability: methods of study, results and interpretation. Toxicon (1991) 1.77
Complex cocktails: the evolutionary novelty of venoms. Trends Ecol Evol (2012) 1.76
The king cobra genome reveals dynamic gene evolution and adaptation in the snake venom system. Proc Natl Acad Sci U S A (2013) 1.68
Venoms as a platform for human drugs: translating toxins into therapeutics. Expert Opin Biol Ther (2011) 1.61
Structural considerations of the snake venom metalloproteinases, key members of the M12 reprolysin family of metalloproteinases. Toxicon (2005) 1.61
Snakebite doesn't cause disseminated intravascular coagulation: coagulopathy and thrombotic microangiopathy in snake envenoming. Semin Thromb Hemost (2010) 1.50
Efficacy and safety of alfimeprase in patients with acute peripheral arterial occlusion (PAO). J Vasc Surg (2010) 1.46
Snake venom disintegrins: evolution of structure and function. Toxicon (2005) 1.43
Inventing an arsenal: adaptive evolution and neofunctionalization of snake venom phospholipase A2 genes. BMC Evol Biol (2007) 1.43
Evolution of an arsenal: structural and functional diversification of the venom system in the advanced snakes (Caenophidia). Mol Cell Proteomics (2007) 1.41
Ending the drought: new strategies for improving the flow of affordable, effective antivenoms in Asia and Africa. J Proteomics (2011) 1.36
Domain loss facilitates accelerated evolution and neofunctionalization of duplicate snake venom metalloproteinase toxin genes. Mol Biol Evol (2011) 1.29
Stroke following Bothrops spp. snakebite. Neurology (2003) 1.25
Development of eptifibatide. Am Heart J (1999) 1.23
Evolutionary origin and development of snake fangs. Nature (2008) 1.20
Practical applications of snake venom toxins in haemostasis. Toxicon (2005) 1.17
Randomised controlled double-blind non-inferiority trial of two antivenoms for saw-scaled or carpet viper (Echis ocellatus) envenoming in Nigeria. PLoS Negl Trop Dis (2010) 1.07
Medically important differences in snake venom composition are dictated by distinct postgenomic mechanisms. Proc Natl Acad Sci U S A (2014) 1.06
Action of snake venom components on the haemostatic system. Blood Rev (1993) 1.05
Preclinical assessment of the efficacy of a new antivenom (EchiTAb-Plus-ICP) for the treatment of viper envenoming in sub-Saharan Africa. Toxicon (2009) 1.02
Venom variability and envenoming severity outcomes of the Crotalus scutulatus scutulatus (Mojave rattlesnake) from Southern Arizona. J Proteomics (2012) 1.01
Integrated "omics" profiling indicates that miRNAs are modulators of the ontogenetic venom composition shift in the Central American rattlesnake, Crotalus simus simus. BMC Genomics (2013) 1.01
Pre-clinical assays predict pan-African Echis viper efficacy for a species-specific antivenom. PLoS Negl Trop Dis (2010) 0.97
Bradykinin-potentiating peptides: beyond captopril. Toxicon (2011) 0.96
Vipers, mambas and taipans: the escalating health crisis over snakebites. Nature (2016) 0.95
Reptilase-R--a new reagent in blood coagulation. Br J Haematol (1971) 0.94
MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in man. Circulation (1993) 0.93
Wound exudate as a proteomic window to reveal different mechanisms of tissue damage by snake venom toxins. J Proteome Res (2009) 0.92
A novel plasminogen activator from snake venom. Purification, characterization, and molecular cloning. J Biol Chem (1995) 0.92
Thrombin-like enzymes from snake venoms: an updated inventory. Scientific and Standardization Committee's Registry of Exogenous Hemostatic Factors. Thromb Haemost (1998) 0.91
Structural and functional characterization of an acidic platelet aggregation inhibitor and hypotensive phospholipase A(2) from Bothrops jararacussu snake venom. Biochem Pharmacol (2002) 0.91
Molecular characterization of an acidic phospholipase A(2) from Bothrops pirajai snake venom: synthetic C-terminal peptide identifies its antiplatelet region. Arch Toxicol (2011) 0.90
Sequence and biological activity of catrocollastatin-C: a disintegrin-like/cysteine-rich two-domain protein from Crotalus atrox venom. Arch Biochem Biophys (1997) 0.90
Current treatment for venom-induced consumption coagulopathy resulting from snakebite. PLoS Negl Trop Dis (2014) 0.89
The Textarin/Ecarin ratio: a confirmatory test for lupus anticoagulants. Thromb Haemost (1993) 0.89
Factor deficiencies in venom-induced consumption coagulopathy resulting from Australian elapid envenomation: Australian Snakebite Project (ASP-10). J Thromb Haemost (2010) 0.88
Research strategies to improve snakebite treatment: challenges and progress. J Proteomics (2011) 0.87
Snakebite is Under Appreciated: Appraisal of Burden from West Africa. PLoS Negl Trop Dis (2015) 0.86
Phase II trial of alfimeprase, a novel-acting fibrin degradation agent, for occluded central venous access devices. J Clin Oncol (2006) 0.84
Isolation and characterization of Textarin, a prothrombin activator from eastern brown snake (Pseudonaja textilis) venom. Toxicon (1994) 0.84
Structure of two genes encoding parallel prothrombin activators in Tropidechis carinatus snake: gene duplication and recruitment of factor X gene to the venom gland. J Thromb Haemost (2007) 0.84
Neurotoxicity in Sri Lankan Russell's Viper (Daboia russelii) Envenoming is Primarily due to U1-viperitoxin-Dr1a, a Pre-Synaptic Neurotoxin. Neurotox Res (2016) 0.84
Purification and characterization of a thrombin like enzyme, elegaxobin II, with lys-bradykinin releasing activity from the venom of Trimeresurus elegans (Sakishima-Habu). Toxicon (2003) 0.83
Antivenom cross-neutralization of the venoms of Hydrophis schistosus and Hydrophis curtus, two common sea snakes in Malaysian waters. Toxins (Basel) (2015) 0.83
Textilinin-1, an alternative anti-bleeding agent to aprotinin: Importance of plasmin inhibition in controlling blood loss. Br J Haematol (2009) 0.83
Comparison of textilinin-1 with aprotinin as serine protease inhibitors and as antifibrinolytic agents. Pathophysiol Haemost Thromb (2005) 0.83
Snake venom fibrinogenolytic and fibrinolytic enzymes: an updated inventory. Registry of Exogenous Hemostatic Factors of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost (1998) 0.82
Thrombocytopenia and platelet hypoaggregation induced by Bothrops asper snake venom. Toxins involved and their contribution to metalloproteinase-induced pulmonary hemorrhage. Thromb Haemost (2005) 0.82
Insularinase A, a prothrombin activator from Bothrops insularis venom, is a metalloprotease derived from a gene encoding protease and disintegrin domains. Biol Chem (2005) 0.81
Cerastocytin, a new thrombin-like platelet activator from the venom of the Tunisian viper Cerastes cerastes. Biochim Biophys Acta (1995) 0.81
Hemorrhage Caused by Snake Venom Metalloproteinases: A Journey of Discovery and Understanding. Toxins (Basel) (2016) 0.81
Diversity of metalloproteinases in Bothrops neuwiedi snake venom transcripts: evidences for recombination between different classes of SVMPs. BMC Genet (2011) 0.81
Characterization of the protein C activator Protac from the venom of the southern copperhead (Agkistrodon contortrix) snake. Toxicon (1987) 0.80
Identification of a novel type of alternatively spliced exon from the acetylcholinesterase gene of Bungarus fasciatus. Molecular forms of acetylcholinesterase in the snake liver and muscle. J Biol Chem (1998) 0.80
Ancrod: understanding the agent. Semin Vasc Surg (1996) 0.80
Preclinical efficacy of Australian antivenoms against the venom of the small-eyed snake, Micropechis ikaheka, from Papua New Guinea: an antivenomics and neutralization study. J Proteomics (2014) 0.78
A novel venombin B from agkistrodon contortrix contortrix: evidence for recognition properties in the surface around the primary specificity pocket different from thrombin. Biochemistry (2000) 0.78
Antivenoms for Snakebite Envenoming: What Is in the Research Pipeline? PLoS Negl Trop Dis (2015) 0.78
Genus Calliophis of Asiatic coral snakes: A deficiency of venom cross-reactivity and neutralization against seven regional elapid antivenoms. Toxicon (2016) 0.77
Hypotensive peptides from snake venoms: structure, function and mechanism. Curr Top Med Chem (2015) 0.77
Assessing SABU (Serum Anti Bisa Ular), the sole Indonesian antivenom: A proteomic analysis and neutralization efficacy study. Sci Rep (2016) 0.77
Feasibility of treating hyperfibrinogenemia with intermittently administered batroxobin in patients with ischemic stroke/transient ischemic attack for secondary prevention. Blood Coagul Fibrinolysis (2007) 0.76
Intracranial haemorrhages associated with venom induced consumption coagulopathy in Australian snakebites (ASP-21). Toxicon (2015) 0.76
Pathogenesis of dermonecrosis induced by venom of the spitting cobra, Naja nigricollis: An experimental study in mice. Toxicon (2016) 0.76
Adverse drug reaction profile of anti-snake venom in a rural tertiary care teaching hospital. J Young Pharm (2013) 0.75
Venom Concentrations and Clotting Factor Levels in a Prospective Cohort of Russell's Viper Bites with Coagulopathy. PLoS Negl Trop Dis (2015) 0.75